Group bulletin
April 17, 2019
 The MA36 study team would like to thank everyone who helped them reach the 34 patient accrual goal for this important study. MA36 is a Randomised, Double-Blind, Parallel group, Placebo-Controlled Multicenter Phase III Study to Assess the Efficacy and Safety of Olaparib versus Placebo as Adjuvant Treatment in Patients with Germline BRCA1/2 Mutations and High Risk HER2 Negative Primary Breast Cancer Who Have Completed Definitive Local Treatment and Neoadjuvant or Adjuvant Chemotherapy. Read More |
 The IND215 trial has been permanently closed.
IND215 is a Phase Ib Study of Selumetinib in Patients with Previously Treated or Untreated Advanced/Metastatic NSCLC Who are Receiving Standard Chemotherapy Regimens.
Primary publication citation
Read More |
 ALC.6 (A041501), A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (A Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) with Newly Diagnosed Precursor B-Cell ALL, has been centrally activated. About the trial Read More |
 All participants at our member sites will be required to attest to the completion of this one-time training requirement by April 30, 2019. Read More |
Sudbury oncologist says clinical trials help treat different types of cancersPublished: April 17, 2019Category: News  Dr Lacey Pitre is an Oncologist and CCTG researcher at the Northeast Cancer Centre in Sudbury, she spoke at a press conference earlier this month to help kick off the Canadian Cancer Society's Daffodil Campaign in Northern Ontario. Read More |
April 03, 2019
 We are fast approaching the CCTG Spring Meeting 2019 #CCTG2019 and here is an update on what you need to know about deadlines and due dates. Read More |
 Did you know that we have some amazing music talent hiding in ranks of CCTG? There has been a friendly (?) music rivalry between Dr. Jim Biagi (Old DOCS New Tricks) and Dr. Dan Renouf (Desolation Sound Machine) and they are letting everyone at the CCTG Spring Meeting be entertained and be the judges of who has the best band. Read More |
Update regarding Good Clinical Practice Revision 2Published: April 03, 2019Category: Group updates  Please be aware that there have been training updates for the Good Clinical Practice Revision 2 implementation. As background, GCP Revision 2 was approved by the ICH regulatory committee November 6, 2016 and Health Canada will implement Revision 2 April 1st, 2019. CCTG communicated a 3 year expiry for GCP certification in spring 2018. Read More |